Atlas Trials

Pen-Administered Low-Dose Dasiglucagon for Prevention and Treatment of Hypoglycemia in People With Type 1 Diabetes

Clinical trial NCT04764968 · COMPLETED

Trial details

NCT number
NCT04764968
Sponsor
Steno Diabetes Center Copenhagen
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Type 1 DiabetesHypoglycemia
Start date
2021-04-27
Primary completion
2021-12-30
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.